Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis
- 29 February 2004
- journal article
- clinical trial
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 23 (2), 129-137
- https://doi.org/10.1016/j.ijantimicag.2003.09.012
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A Controlled Trial of Immunotherapy for Asthma in Allergic ChildrenNew England Journal of Medicine, 1997
- A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander ProjectJournal of Antimicrobial Chemotherapy, 1996
- Antimicrobial Resistance and Type Distribution of Streptococcus pneumoniae Isolates Causing Systemic Infections in Germany, 1992-1994Clinical Infectious Diseases, 1995
- Statistics notes: Absence of evidence is not evidence of absenceBMJ, 1995
- Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task ForceEuropean Respiratory Journal, 1995
- Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysisJAMA, 1995
- Causative Organisms in Acute Exacerbation of Chronic Airways Disease and Response to Ofloxacin TherapyDrugs, 1995
- Management of Infections Caused by Antibiotic-Resistant Streptococcus PneumoniaeNew England Journal of Medicine, 1994
- Extremely High Incidence of Antibiotic Resistance in Clinical Isolates of Streptococcus pneumoniae in HungaryThe Journal of Infectious Diseases, 1991
- Antibiotic resistance and serotypes of 100 Streptococcus pneumoniae strains isolated in a children's hospital in Barcelona, SpainAntimicrobial Agents and Chemotherapy, 1985